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Chapter I. 
Preface 
Genetic information is transferred from DNA into proteins. This biological phenomenon 
is termed ‘Central Dogma’. Its flow can be divided into DNA replication, transcription, 
and translation. RNAs play pivotal roles in the transcription and translation steps. For 
example, DNA is transcribed into messenger RNA (mRNA) and this mRNA is 
translated by ribosomes, which are composed of ribosomal RNAs (rRNAs) and 
ribosomal proteins. During translation, transfer RNAs (tRNAs) bring specific amino 
acids to the ribosomes. The functions of these RNAs can be regulated post-
transcriptionally (referred to as RNA modifications). RNA modifications are present in 
all kingdoms of life. Further, over 100 different types of modifications have been 
identified (1). 
Among the known RNA modifications, the N1-methyladenosine (m1A) 
modification, which is an N1 atom methylated ribonucleotide, is well-studied. Over 50 
years ago, m1A was first documented using yeast and mammalian RNAs (2). Until now, 
m1A modifications in tRNAs have been shown to increase its structural stability and 
induce correct folding (3). Additionally, enzymes catalyzing the m1A modification of 
tRNA have been identified not only in yeast but also in mammals (4, 5). On the other 
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hand, the methyltransferase(s) and physiological functions of the rRNA m1A 
modification, especially in multicellular organisms, are poorly understood. 
    Recently, Peifer et al. have reported that yeast rRNA processing protein 8 (Rrp8) is 
responsible for the m1A modification of yeast 25S rRNA (6). Therefore, in chapter II, I 
focused on the mammalian homolog of yeast Rrp8, nucleomethylin (NML), and 
investigated its involvement in the rRNA m1A modification using mammalian cells. I 
showed that NML is required for the m1A modification in human and mouse 28S rRNA, 
and contributes to formation of the 60S ribosomal subunit. Furthermore, I demonstrated 
that NML regulates the cell growth via a p53-dependent mechanism. 
Caenorhabditis elegans (C. elegans) is a frequently used model organism for 
various biological studies, such as development, behavior, and aging (7, 8). Hence, in 
chapter III, to reveal the physiological significance of the rRNA m1A modification in 
vivo, I investigated the function of T07A9.8, a C. elegans homolog of human NML. The 
results demonstrated that T07A9.8 is involved in the regulation of autophagy and 
lifespan. Notably, it has been considered that autophagy plays a key role in longevity (9-
12). Collectively, these novel discoveries suggest the proposition that the rRNA m1A 
modification links autophagy to the regulation of lifespan in multicellular organisms. 
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Chapter II. 
Mammalian NML-mediated m1A modification of rRNA links 
ribosomal subunit formation to cell proliferation 
in a p53-dependent manner 
Abstract 
Ribosomal RNAs (rRNAs) act as scaffolds and ribozymes in ribosomes, and these 
functions are modulated by various post-transcriptional modifications. However, the 
biological roles of base methylation, a well-conserved modification of rRNAs, are 
largely unknown. 
In this study, using human and mouse cells, I demonstrated that a nucleolar protein, 
nucleomethylin (NML; also known as RRP8), is required for the N1-methyladenosine 
(m1A) modification of 28S rRNA. Furthermore, NML contributes to the 60S ribosomal 
subunit formation. Intriguingly, NML depletion increases ribosomal protein L11 
(RPL11) levels in the ribosome-free fraction. This increment upregulates the p53 
protein levels through an RPL11-MDM2 complex, and thereby activates the p53 
pathway. In consequence, the growth of NML-depleted cells is suppressed in a p53-
dependent manner. 
These findings reveal a novel biological function of the rRNA m1A modification, 
which links ribosomal subunit formation to p53-mediated inhibition of cell proliferation 
in mammalian cells. 
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Introduction 
Ribosomal RNAs (rRNAs) function as scaffolds for ribosomal proteins and ribozymes 
for peptide bond formation (13, 14). Biosynthesis of rRNA comprises transcriptional 
and post-transcriptional modification of precursor (pre)-rRNAs as well as the 
processing of pre-rRNAs into mature 28S, 18S and 5.8S rRNAs (15). Nucleotide 
modifications of rRNA regulate the function and stability of ribosomes (16). There are 
three main types of chemical modifications of rRNA – conversion of uridine to 
pseudouridine (pseudouridylation); methylation of 2′-hydroxyls (2′-O-ribose 
methylation); and alteration of bases, most of which undergo methylation at its different 
positions (base methylation) (16). Of these modifications, base methylations are the 
most conserved in terms of their total number and position among living organisms, and 
are commonly found at approximately ten positions in eukaryotic rRNAs (17, 18). Base 
methylation is considered to expand the structural repertoire of RNA through facilitating 
base stacking by increasing hydrophobicity and adjusting steric hindrance (19). To date, 
base methylation of rRNA and the genes responsible for it (Bud23, Rrp8, Nop2, Rcm1, 
Bmt2, Bmt5 and Bmt6) have been identified in budding yeast (6, 20-22). The recent 
report has shown that yeast and worm homologs of human NSUN5 methylate C2278 of 
Saccharomyces cerevisiae 25S rRNA and C2381 of Caenorhabditis elegans 26S rRNA. 
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In addition, the reduction in the levels of NSUN5 homologs decreases translational 
fidelity in yeast and increases the lifespan of S. cerevisiae, C. elegans and Drosophila 
melanogaster (23). Until now, the human homolog of yeast Bud23, WBSCR22 
(Merm1), has been shown to mediate N7-methylation of G1639 of 18S rRNA and 
contribute to its maturation in cells (24). However, little is known about the base 
methyltransferase of 28S rRNA in mammals. 
In all organisms, ribosomes serve as the sole site of protein synthesis, and their 
biogenesis is strictly regulated. The mammalian ribosomes comprise two subunits 
composed of rRNAs and ribosomal proteins (25, 26). The small subunit (40S) is formed 
from a single molecule of rRNA (18S rRNA) and 33 ribosomal proteins (ribosomal 
proteins of the small ribosomal subunit; RPSs). Conversely, the large subunit (60S) 
contains three rRNA molecules (28S, 5.8S, and 5S rRNA) and 47 ribosomal proteins 
(ribosomal proteins of the large subunit; RPLs). Interestingly, the defects of ribosome 
biogenesis are coupled to inhibition of cell proliferation that is mediated by p53 (27-29). 
p53 functions as a tumor suppressor, and its activation induces cell cycle arrest and 
apoptosis, resulting in the suppression of cell growth (30-32). In addition to these 
reports, recent studies have been suggested that quantitative and qualitative changes in 
ribosomes are associated with numerous physiologic and pathologic events (33-37). 
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However, it remains unclear whether and how the base methylations of rRNAs regulate 
ribosomal functions and related biological events in mammals. 
Nucleomethylin (NML; also known as RRP8) is a nucleolar protein that binds to 
dimethyl lysine at position 9 of histone H3 (H3K9me2) in cells and suppresses rRNA 
transcription in response to glucose deprivation (38, 39). NML contains the Rossmann-
fold methyltransferase-like domain in its C-terminal half, and binds to S-adenosyl-L-
methionine (SAM), while NML does not exhibit methyltransferase activity toward 
histones (39). Recently, the yeast NML homolog Rrp8 has been identified as a gene 
responsible for the SAM-dependent N1-methyladenosine (m1A) modification in the 25S 
rRNA (6). However, the contribution of NML to m1A modification has yet to be 
elucidated. 
In this study, using mammalian cells, I revealed that NML is responsible for m1A 
modification of 28S rRNA and contributes to the formation of 60S ribosomal subunit, 
and that NML deficiency inhibits cell proliferation in a p53-dependent manner. 
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Materials and Methods 
Cell culture 
Human epithelial adenocarcinoma HeLa cells were provided by the RIKEN Catalysis 
Research Center through the National Bio-Resource Project of the Ministry of 
Education, Culture, Sports, Science and Technology, Japan. SV40 large T-antigen 
transformed NML WT and KO mouse embryonic fibroblasts (MEFs) were generated 
from C57BL/6J background wildtype and NML-KO mice, respectively (40). Human 
colon carcinoma HCT116 p53+/+ and p53−/− cells were kindly provided by Dr. Bert 
Vogelstein (John Hopkins University, USA) (41). All animal experiments were 
approved and performed in accordance with the guidelines for the care and use of 
laboratory animals at University of Tsukuba. For MEF isolation, embryos at 13.5 days 
post-coitum from C57BL/6J mice (CLEA Japan, Japan) were used. After the removal of 
the head and visceral tissues, the remaining bodies were washed and dissociated. Cells 
were plated on dishes and incubated 37 °C with 5% CO2. The next day, floating cells 
were removed by washing in phosphate-buffered saline (PBS). MEFs were used within 
three passages. All cells were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM; Gibco, Thermo Fisher Scientific, USA) supplemented with 10% fetal bovine 
serum (FBS; Gibco, Thermo Fisher Scientific) and penicillin-streptomycin (Sigma-
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Aldrich, USA). 
 
Antibodies 
Antibodies against the following proteins and epitopes were used in my study: anti-E-
actin (A5316; Sigma-Aldrich); anti-D-tubulin (T5168; Sigma-Aldrich); anti-Histone H3 
(9715; Cell Signaling Technology, USA); anti-1-methyladenosine (D345-3; MBL, 
Japan); anti-RPL11 (14382; Cell Signaling Technology); anti-MDM2 (sc-96; Santa 
Cruz Biotechnology, USA); anti-p53 (DO-1; sc-126; Santa Cruz Biotechnology); anti-
p21 (F-5; sc-6246; Santa Cruz Biotechnology); anti-Bax (ab7977; Abcam) and an 
unconjugated affinity purified isotype control immunoglobulin (IgG) from mouse (sc-
2025; Santa Cruz Biotechnology). Previously reported anti-human and mouse NML 
antibodies were used (39, 40). 
 
RNA interference experiment 
To generate stable knockdown cell lines, cells were transfected with the piGENE™ hU6 
plasmid (iGENE Therapeutics, Japan) containing sequences targeting NML, green 
fluorescent protein (GFP) or luciferase (Luc). The transfected cells were selected with 
puromycin. The target sequences were: 
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5’-GCCGCTTTGAGGATGTTCGAA-3’ for shNML#1 
5’-GGGTAGTACTACAAATGATCC-3’ for shNML#2 
5’-GGCTACGTCCAGGAGCGCACC-3’ for shGFP 
5’-GTGCGCTGCTGGTGCCAACCC-3’ for shLuc. 
For transient knockdown, cells were transfected with 20 nM of Stealth RNAi™ short 
interfering RNA (siRNA) (Invitrogen, USA) using Lipofectamine® RNAiMAX 
(Invitrogen) according to the manufacturer’s protocol. The target sequences were as 
follows: 
5’-CCGCUUUGAGGAUGUUCGAACCUUU-3’ for siNML#1 (human) 
5’-CCUCAUACAUUAAGCCGCAAGCAGU-3’ for siNML#2 (human) 
5’-CCAAACUCGGCUUUAAGAUUAUCUA-3’ for siNML (mouse) 
5’-ACACAUCGAUCUGGGUAUCAAAUAU-3’ for siRPL11. 
Stealth RNAi™ Luciferase Reporter control (siLuc) was used as a negative control. 
 
Plasmid construction and mutagenesis 
A plasmid containing mouse wild-type NML was constructed by inserting the Hind III-
Not I (blunt ended with Klenow)-digested fragment from FLAG- and HA-tagged mouse 
NML in pcDNA3 into the Xho I (filled with Klenow) site of the plasmid pPB-CAG. 
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EBNXN (kindly provided by Dr. Allan Bradley, Wellcome Trust Sanger Institute, UK). 
Mutations were introduced by performing site-directed mutagenesis and PCR. The 
primer sequences were as follows (induced mutations are underlined): 
mouse NML mt1 (G317D, G319R), 5’-GCTGACTTTGACTGTAGAGATTGCCGC-3’ 
mouse NML mt2 (G317Q), 5’-GCTGACTTTGGCTGTGAAGATTGCCGC-3’. 
 
RNA immunoprecipitation (RIP) 
RIP was performed as previously described (42) with minor modifications. For RIP 
against NML using nuclear lysates, cells were harvested and resuspended in 450 Pl 
buffer A [10 mM HEPES (pH 7.5), 10 mM KCl, 0.1 mM EDTA] (43) and kept on ice 
for 15 min. Fifty microliters of buffer A including 5% Nonidet P-40 (NP-40) were 
added. Nuclei were pelleted by centrifugation at 800 g for 5 min at 4 °C. Then, whole 
cells or nuclei were suspended in 200 Pl cold lysis buffer [10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (pH 7.5), 300 mM KCl, 5 mM MgCl2, 0.5% NP-40, 1 
mM dithiothreitol, EDTA-free protease inhibitor cocktail (Nacalai Tesque, Japan) and 
100 U/ml RNase Inhibitor (Toyobo, Japan)]. The whole-cell or nuclear extracts were 
centrifuged at 15,000 g for 15 min at 4 °C, and the supernatant was pre-cleared using 
protein G Sepharose® beads (GE Healthcare, UK) and treated with DNase I (Wako Pure 
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Chemical Industries, Japan) (60 U/100 Pl lysate) for 30 min on ice. The samples (2-10 
Pg) were incubated with pre-binding antibodies (5 Pg) and protein G Sepharose® beads 
in 1000 Pl NT2 buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM MgCl2 and 
0.05% NP-40] including 100 U of RNase inhibitor, 10 mM dithiothreitol and 20 mM 
EDTA overnight at 4 °C. The beads were washed twice with NT2 buffer and 
resuspended in 100 Pl of NT2 buffer. The suspension was mixed with 100 Pl of 
proteinase K buffer [30 Pg proteinase K, 20 mM Tris-HCl (pH 7.8), 10 mM EDTA and 
1% sodium dodecyl sulfate (SDS)] and incubated for 30 min at 55 °C. After 
centrifugation, RNAs were purified from the supernatant using phenol-chloroform-
isoamyl alcohol and analyzed by performing qRT-PCR. The whole-cell or nuclear 
extracts were used as input samples for normalization of qRT-PCR data. 
 
Western blotting 
For Western blotting, cells were lysed with RIPA buffer [20 mM Tris-HCl (pH7.5), 150 
mM NaCl, 2 mM EDTA, 0.8% NP-40, 0.1% SDS and 0.5% sodium deoxycholate]. Cell 
extracts were separated by performing SDS-PAGE and transferred to a polyvinylidene 
difluoride membrane using transfer apparatus according to the manufacturer’s protocol 
(Bio-Rad Laboratories, USA). The antibodies used are described in the Antibodies 
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section. For quantitative analyses of Western blotting data, band intensities were 
measured by using Multi Gauge version 3.0 software (Fujifilm, Japan). Each protein 
level was normalized to the protein levels of E-actin. 
 
qRT-PCR 
To quantify rRNA or mRNA levels, aliquots of total RNA (500 ng) were reverse 
transcribed with a pd (N)6 random primer and 250 μM of deoxy nucleoside 
triphosphates (dNTPs). Quantitative reverse-transcription (qRT)-PCR was performed 
with primers for the indicated rRNAs or genes (Table 1). The expression level of each 
gene in human and mouse cells was normalized to the mRNA levels of genes encoding 
human E-actin (ACTB) and mouse cyclophilin (Ppia), respectively. 
 
Detection of rRNA methylation with site-specific semi-quantitative RT-
PCR 
To quantify rRNA methylation levels, I performed a site-specific rRNA methylation 
assay based on qRT-PCR (35, 37). Total RNA was extracted and purified using Sepasol-
RNA I Super G (Nacalai Tesque) according to the manufacturer’s instructions. Total 
RNA (500 ng) were reverse transcribed using ReverTra Ace® (Toyobo) and 1 μM of 
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each reverse primer targeting a sequence downstream to a specific methylation site, 
with either a low (2.5 μM) or high (250 μM) dNTP concentration. qRT-PCR was 
performed with SYBR® Premix Ex Taq™ II (Takara, Japan) using a Thermal Cycler 
Dice™ Real-Time System (Takara). The methylation level was calculated following the 
function 2(CTlow - CThigh), where the CT (threshold cycle) value obtained with the qRT-
PCR reaction at the low dNTP concentration was normalized to that obtained at the high 
dNTP concentration. The primer sequences used in this assay are listed on Table 2. 
 
Primer extension 
Primer extension was performed as per described protocols (21, 44) with minor 
modifications. One micromole of DNA primer was 32P-5’-terminally labeled by 
incubation in a final volume of 25 Pl with 15 PCi J-[32P]ATP and 9 U of polynucleotide 
kinase in protruding kinase buffer (Toyobo). The mixture was incubated at 37 °C for 1 
h. The reaction mixture was then purified using Illustra™ MicroSpin™ G-25 columns 
(GE Healthcare). For the extension reaction, 0.5 Pl of the 32P-5’-phosphorylated primer 
was annealed by heating for 3 min at 95 °C, followed by cooling on ice using 0.2 Pg 
total RNA in 4.75 Pl RT buffer (Toyobo) containing 2.5 PM dNTPs. Annealed primers 
were extended using 0.25 Pl ReverTra Ace® (25 U) for 1 h at 42 °C, stopped by the 
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addition of 5 Pl formamide loading dye and frozen at −80 °C. Primer extension products 
were resolved by performing electrophoresis on 8% polyacrylamide gels containing 4 M 
urea. Gels were dried and exposed to Amersham Hyperfilm™ ECL (GE Healthcare). 
The primer sequences for primer extension are listed on Table 2. 
 
Quantification of methylated ribonucleosides with LC-MS/MS 
28S rRNA was isolated from total RNA by performing agarose gel electrophoresis and 
gel extraction with the NucleoSpin® Gel and PCR Clean-up system (MACHEREY-
NAGEL, Germany) according to the instruction manual. After denaturation by heating 
at 100 °C for 3 min, 1-2 Pg of 28S rRNA was chilled on ice immediately. Denatured 
RNA was hydrolyzed by nuclease P1 (1 U, Wako Pure Chemical Industries) in 10 mM 
ammonium acetate buffer (pH 5.3) at 45 °C for 2 h, subsequently dephosphorylated by 
incubating with phosphodiesterase I (0.0002 U, Sigma-Aldrich), alkaline phosphatase 
(0.3 U, Toyobo) and 0.1 volume of 1 M ammonium bicarbonate buffer (pH 7.9) at 37 °C 
for 2 h, as described previously (45). Ten pmol of br5U (Tokyo Chemical Industry, 
Japan) were added into the mixture as an internal standard. The enzymes were 
subsequently removed by acetone precipitation. The supernatant was evaporated, and 
the ribonucleoside pellet was dissolved with 15 Pl of HPLC-grade water (Wako Pure 
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Chemical Industries). 
Individual ribonucleosides were quantified using a Shimadzu Nexera™ UHPLC 
system coupled to LCMS-8050™ triple quadrupole mass spectrometer (Shimadzu, 
Japan). Reverse-phase HPLC separation was carried out using a Kinetex™ 2.6 Pm C18 
column (2.1×150 mm, Phenomenex, USA) with a VANGUARD™ Pre-Column (2.1×5 
mm, Waters, USA) at 30 °C with 0.1% formic acid in 80% acetonitrile (solvent B) 
gradient in 0.1% formic acid (solvent A) at a flow rate of 0.2 ml/min. The water-
dissolved sample (5 Pl) was injected and eluted with the following gradient elution: 
initial isocratic elution with 0% solvent B for 3 min, followed by linear gradient elution 
from 0 to 8% B until 19 min, jumping to 100% B within 2 min and holding the status 
until 25.5 min. The column was then subsequently returned to the start conditions 
within 1 min and equilibrated for 4.5 min before the next sample injection. For 
determining elution positions of ribonucleosides on the chromatogram, standard 
chemicals of m1A (Santa Cruz Biotechnology), N6-methyladenosine (m6A) (Carbosynth, 
UK), and br5U were used, and their retention times were revealed as 2.23 min, 15.1 min 
and 11.58 min, respectively. 
The mass spectrometer was operated with an ion-spray source at 300 °C in positive 
ion mode, with unit resolution for Q1 and Q3, and other optimized parameters: interface 
16 
 
voltage, 4.0 kV; interface current, 0.1 PA; flow rate of nebulizer gas, 3 l/min; flow rate 
of heating gas, 10 l/min; flow rate of drying gas, 10 l/min; collision gas (Ar), 270 kPa; 
desolvation line temperature, 250 °C; heat block temperature, 400 °C; conversion 
dynode potential, 10 kV; detector potential, 2.44 kV. Multiple reaction monitoring was 
used for detection of nucleosides with a dwell time of up to 100 ms. Q1 was set to 
transmit the parental ions MH+ at m/z 282.1, 282.1 and 324.6 for m1A, m6A, and br5U, 
respectively. The daughter ions were monitored in Q3 at m/z 150.1, 150.1, and 193.05 
for m1A, m6A, and br5U, respectively. Linear calibration curves were obtained daily. All 
of the solvents and reagents used in this analysis were HPLC grade. The control of 
instrument and data analyses were performed using the LabSolutions LCMS (Ver.5.60) 
software (Shimadzu). 
 
m1A-RIP 
For RIP against m1A containing RNA, total RNAs were extracted using Sepasol-RNA I 
Super G and treated with DNase I. Purified RNAs were fragmented using an NEBNext® 
Magnesium RNA Fragmentation Module (New England Biolabs, USA). After adding 
20 Pg of glycogen, fragmented RNAs were precipitated with ethanol and resuspended in 
100 Pl of IPP buffer [10 mM Tris-HCl (pH 7.5), 150 mM NaCl and 0.1% NP-40]. RNA 
17 
 
samples were added to 100 Pl of an antibody mixture that included IPP buffer and 50 Pl 
of Protein G Sepharose® beads (50% slurry). The mixture was rotated overnight at 4 °C. 
The beads were washed twice with IPP buffer. Immunoprecipitated RNAs were purified 
by phenol–chloroform-isoamyl alcohol extraction, and analyzed by qRT-PCR. Total 
RNAs were used as input samples for normalization of qRT-PCR data. 
 
rRNA processing 
Cells were cultured with methionine-free medium for 1 h, and then with methionine-
free medium containing 20 PCi/ml 32P-labeled inorganic phosphate for 1 h (28). The 
metabolic labeling media were removed, and the cells were cultured with normal 
medium for 3 h. After cell harvesting, RNA was extracted using a FastPure™ RNA Kit 
(Takara) and analyzed by glyoxal agarose gel electrophoresis. Total RNA was visualized 
by ethidium bromide staining. 
 
Bimolecular fluorescence complementation 
The BiFC assay was performed as described previously (46). To generate plasmids 
expressing BiFC-tagged ribosomal proteins, the sequences of RPS18 and RPL11 were 
PCR-amplified from the cDNA of HeLa cells using primers tagged with SacI and XbaI 
18 
 
or ApaI and KpnI, respectively. The RPS18 and RPL11 segments were cloned into 
pBiFC-VN173 (22010, Addgene, USA) and pBiFC-VC155 (22011, Addgene), 
respectively (47). Using Lipofectamine® LTX (Invitrogen), these BiFC plasmids were 
co-transfected with a pmCherry-N1 plasmid (Clontech Laboratories, USA), which was 
used as an internal control. Twenty-four hours after transfection, cells were further 
cultured with or without 100 Pg/ml puromycin for 24 h. The cells were washed twice 
with STM buffer [PBS with 2% FBS] and resuspended in 500 Pl of STM buffer. The 
fluorescence intensities of Venus and mCherry were measured by a BD FACSAria™ II 
(BD Biosciences, USA). The BiFC signal emitted by a cell was calculated using the 
following function: (fluorescent intensity of Venus)/(fluorescent intensity of mCherry), 
following the previous method (48). 
 
Sucrose density gradient centrifugation 
Sucrose density gradient centrifugation was performed as previous described manner (6, 
49). Briefly, to investigate ribosomal subunit formation, cells were treated with 100 
Pg/ml cycloheximide (CHX) for 5 min at 37 °C. The cells were washed twice with PBS 
containing CHX (100 Pg/ml) and lysed with lysis buffer [15 mM Tris-HCl (pH 7.5), 
300 mM NaCl, 25 mM EDTA, 1% Triton X-100, 0.5 mg/ml heparin, 100 Pg/ml CHX, 
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1× EDTA-free protease inhibitor cocktail (Nacalai Tesque) and 100 U/ml RNase 
inhibitor (Toyobo)]. The lysate was centrifuged at 9300 g for 10 min at 4 °C and loaded 
onto a linear 20-50% sucrose gradient buffer in 15 mM Tris-HCl (pH 8.0), 25 mM 
EDTA, and 300 mM NaCl. Centrifugation was conducted at 40,000 rpm for 2 h at 4 °C 
with a SW-41 Ti rotor (Beckman Coulter, USA), and fractions were collected from the 
top of the gradient (#1 to #18). The 18S and 28S rRNA levels in the fractions #1 to #18 
were quantified by conducting qRT-PCR and normalized against those rRNA levels in 
an input RNA extracted from cells. The ratio of 18S rRNA : 28S rRNA (18S rRNA 
divided by 28S rRNA) was calculated as the small : large ribosomal subunit ratio. 
To obtain the ribosomal or ribosome-free fractions, I performed sucrose density 
gradient centrifugation using lysis and gradient buffers containing 15 mM MgCl2 
instead of 25 mM EDTA. 18S and 28S rRNAs, and E-actin proteins were used as 
indicators for the ribosomal and ribosome-free fractions, respectively (50, 51). 
 
Analysis of protein synthesis with 35S-methionine 
The quantification of protein synthesis rate was performed as previously described (52, 
53). Cells were plated onto 12-well plates in complete medium, and in the case of 
HCT116 cells, siRNAs were transfected. One day after cell seeding or 3 days after 
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transfection, the culture medium was switched to methionine-free DMEM with or 
without 50 Pg/ml CHX for 30 min at 37 °C, and cells were incubated with the same 
medium containing 20 PCi/ml 35S-methionine (PerkinElmer, USA) for 2 h at 37 °C. 
Cells were then washed twice with ice-cold PBS and solubilized in 50 Pl of RIPA buffer 
containing protease inhibitors. The supernatant was analyzed using a liquid scintillation 
counter (Beckman Coulter) and obtained values were normalized against the total 
protein content. 
 
Co-immunoprecipitation 
Cells were lysed in RIPA buffer supplemented with EDTA-free protease inhibitor 
cocktail. The same amounts of protein lysates were resuspended in TNE buffer [10 mM 
Tris-HCl (pH7.5), 150 mM NaCl, 1 mM EDTA, 1% NP-40] supplemented with EDTA-
free protease inhibitor cocktail, and were immunoprecipitated with the indicated 
antibodies (1.8 Pg/ml) and Dynabeads® Protein G (Invitrogen). Bound proteins were 
then analyzed by Western blotting. 
 
Cell cycle analysis by 5-ethynyl-2’-deoxturidibe staining 
For 5-ethynyl-2’-deoxyuridine (EdU) staining, cells were plated (1×105 cells/well in a 
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6-well plate) and cultured for 3 days after siRNA transfection. Then, cell cycle 
evaluation was conducted using a Click-iT® EdU Imaging Kit (Invitrogen), according to 
the manufacturer’s protocol. First, cells were labeled with 10 PM EdU (Invitrogen) in 
culture medium for 1 h at 37 °C. For subsequent DNA staining, EdU-stained cells were 
incubated with 2 Pg/ml Hoechst 33342 (Sigma-Aldrich) for 10 min. After the staining, 
cells were washed with PBS and subjected to FACS by using a BD FACSAria™ II 
instrument. 
 
Terminal deoxynucleotidyl transferase dUTP-biotin nick labelling 
assay 
Cells were plated onto poly-D-lysine coated 8-well chamber slides (BD Biosciences) 
(1.6×104-2.4×104 cells/well) and cultured for 3 days after siRNA transfection. Then, the 
cells were fixed with 4% paraformaldehyde in PBS for 25 min at 4 °C, and in situ 
detection of apoptotic cells was performed using DeadEnd™ Fluorometric TUNEL 
System (Promega, USA), according to the manufacturer’s instructions. The nuclei were 
then counterstained using 2 Pg/ml Hoechst 33342. The cells were observed using the 
fluorescent microscope imaging system BIOREVO BZ-9000 (Keyence, Japan), and 
TUNEL-positive cells were measured in three fields per sample. The percentage of 
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TUNEL-positive cells was calculated as follows: (TUNEL-positive/total cells) × 100. 
 
Cell proliferation assay 
To analyze the cell proliferation rate, cells were seeded (1×105 cells/well) in 6-well 
plates and transfected them with the indicated siRNA. The cells were then trypsinized 
into single-cell suspensions and automatically counted using a TC10™ Automated Cell 
Counter (Bio-Rad Laboratories) on days 1, 2, 3, and 4, where the first day after seeding 
was day 0. 
 
Statistical analysis 
The unpaired Student’s t-test was used to compare two groups, and one-way ANOVA 
followed by Tukey’s post-hoc test was used to compare multiple groups. The statistical 
analysis of fold-change data was performed by bootstrap and permutation tests using the 
web application BootstRatio (54). 
 
 
23 
 
Results 
NML binds to 28S rRNA 
A large number of RNA methyltransferases interact with the specific target RNA 
through their substrate-binding site (55). To date, Yang et al. have shown the interaction 
of NML with rRNAs using human non-small lung carcinoma H1299 cells (56). To 
confirm the interaction between NML and 28S rRNA in human epithelial 
adenocarcinoma HeLa cells, I performed RNA immunoprecipitation (RIP) experiments 
using an antibody against NML. In this assay, endogenous NML proteins were 
precipitated using an antibody against NML. After immunoprecipitation, RNAs were 
then purified from the precipitates, and 28S rRNA levels were quantified by performing 
quantitative reverse-transcriptase (qRT)-PCR using a specific primer set (Table 1). 28S 
rRNA was co-immunoprecipitated with NML from the whole cell (Fig. II-1A). 
Furthermore, I isolated the nuclear extracts from the cells, and detected the interaction 
between 28S rRNA and NML (Fig. II-1B). On the other hand, 5S rRNA was not 
significantly co-immunoprecipitated with NML (Fig. II-1A, B). From these results, I 
confirmed that NML has the potential to associate with 28S rRNA. 
 
 
24 
 
NML is required for methylation of 28S rRNA 
In yeast 25S rRNA, two sites with the m1A modification have been identified (6, 21), 
and these adenosine molecules and also the neighboring sequences are well conserved 
among eukaryotes, including humans and mice (Fig. II-2A; A645 and A2142 of 25S 
rRNA in Saccharomyces cerevisiae correspond to A1309 and A3625 of 28S rRNA in 
Homo sapiens, and A1136 and A3301 of 28S rRNA in Mus musculus, respectively). 
Therefore, to investigate the effect of NML on rRNA methylation, I performed site-
specific semi-quantitative RT-PCR analysis (Fig. II-2B). I used HeLa cells stably 
expressing NML-knockdown (KD) constructs (shNML#1 and #2) (Fig. II-2C). 
Methylation levels around A1309, which is methylated by Rrp8 in yeast (6), were 
significantly lower in shNML-transfected cells than in control cells expressing shRNAs 
against green fluorescent protein (shGFP) (Fig. II-2D; left). In contrast, methylation 
levels around A3625, which is methylated by Bmt2 in yeast (21), were very low in 
control cells [rRNA methylation levels around A1309 and A3625 (mean ± S.D.) were 
19.05 ± 0.47 and 1.32 ± 0.21, respectively.]. In addition, the methylation levels were not 
markedly changed by knockdown of NML (Fig. II-2D; right). Consistently, methylation 
levels around A1136, which corresponds to A1309 of 28S rRNA in humans, were 
reduced in NML-knockout (NML KO) immortalized mouse embryonic fibroblasts 
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(MEFs) compared with in NML wild-type (NML WT) MEFs (Fig. II-2E, F; left). 
Furthermore, methylation levels around A3301 were quite low and were not affected by 
NML depletion (Fig. II-2F; right). 
Next, to determine the precise methylation site, I performed primer extension 
analysis. Strong stop signals at positions A1309 and A1136 were observed in 28S 
rRNAs of shGFP and NML WT cells (Fig. II-2G). By contrast, these stop signals were 
reduced in 28S rRNAs of NML KD and KO cells. Moreover, the reduction of 
methylation levels around A1136 was attenuated by the expression of FLAG- and 
hemagglutinin (HA) (FLAG-HA)-tagged NML, but not by the expression of control 
EGFP (Fig. II-2H, I). These results indicate that NML is responsible for the methylation 
at A1309 and A1136 in 28S rRNA of human and mouse cells. 
 
Rossmann-fold methyltransferase-like domain of NML is essential for 
28S rRNA methylation 
A previous study has revealed that the C-terminal region of NML contains a Rossmann-
fold methyltransferase-like domain, which interacts with the methyl donor SAM (39) 
(Fig. II-3A). To investigate whether this domain is indispensable for 28S rRNA 
methylation induced by NML, I performed site-specific semi-quantitative RT-PCR 
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analysis using the immortalized MEFs, which were stably expressed FLAG-HA-tagged 
wild-type NML (NML-wt) or mutated NML constructs (NML-mt1 or NML-mt2). These 
mutated NML proteins lack the SAM-binding ability (39) (Fig. II-3A, B). Expression of 
NML-wt increased rRNA methylation levels around A1136 in NML KO MEFs (Fig. II-
3C). Conversely, no significant enhancement of rRNA methylation was induced by 
expression of control EGFP, NML-mt1 or NML-mt2 in NML KO MEFs. These results 
suggest that NML regulates the methylation of 28S rRNA through its methyltransferase-
like domain-dependent mechanism. 
 
NML is responsible for m1A modification of 28S rRNA 
To investigate whether the NML-mediated 28S rRNA methylation is m1A modification 
or not, I quantified the base modifications, included in a 28S rRNA fragment by liquid 
chromatography/tandem mass spectrometry (LC-MS/MS). In NML KD and KO cells, 
the peaks corresponding to m1A were reduced compared with those in control KD and 
NML WT cells (Fig. II-4A, B). Moreover, RIP experiments using an antibody against 
m1A revealed that m1A modifications around A1309 and A1136 were significantly 
reduced by NML depletion (Fig. II-4C, D). From these results, I revealed that NML is a 
responsible factor for m1A modifications at positions 1309 and 1136 in human and 
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mouse 28S rRNA. 
 
NML hardly alters rRNA transcription and processing under high 
glucose environments 
Previous reports have shown that NML inhibits rRNA transcription in human cells 
under glucose deprivation (39). Moreover, it has been reported that the depletion of 
certain factors involved in ribosome biogenesis inhibits rRNA transcription and/or 
processing (57). To evaluate the effect of NML KD on rRNA transcription and 
processing under conditions with 4.5 g/l glucose used in this study, I checked pre- and 
mature rRNA levels. In shNML-expressing HeLa cells, pre- and mature rRNA levels 
were unchanged in comparison with those in control cells (Fig. II-5A). Furthermore, the 
analysis of pre-rRNA processing using metabolic labeling with 32P-orthophosphate 
showed that there was not substantial change in the distribution patterns on gels of pre-
rRNAs (47S and 45S, and 32S) and mature rRNAs (28S and 18S) between shGFP- and 
shNML-expressing HeLa cells (Fig. II-5B). These results indicate that NML modulates 
rRNA base methylation without altering rRNA transcription and processing under high 
glucose conditions. 
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NML participates in the ribosomal subunit association 
Modifications of rRNA contribute to the ribosomal subunit formation and association 
(16, 58-60). To investigate the effect of NML reduction on the interaction between 
ribosomal subunits, I conducted bimolecular fluorescence complementation (BiFC) to 
visualize ribosomal subunit joining (46). The 40S ribosomal protein S18 (RPS18) and 
60S ribosomal protein L11 (RPL11), which are positionally adjacent to each other on 
the surface of each subunit, were tagged with the N- or C-terminal halves of the yellow 
fluorescent protein Venus, respectively (yielding S18-VN and L11-VC; Fig. II-6A). 
Subunit interaction was detected as Venus signal (hereafter referred to as BiFC signal). I 
quantified the BiFC signal using fluorescence activated cell sorting (FACS) and 
confirmed that the signal was only detected from the S18-VN and L11-VC co-
transfected cells (Fig. II-6B; S18-VN/L11-VC). Moreover, the BiFC signal was 
dramatically reduced when cells were treated with puromycin, an aminoacyl-tRNA-like 
molecule which induces 80S ribosome dissociation (46, 61) (Fig. II-6B-D). These 
results support that the BiFC signal derived from S18-VN and L11-VC expression is a 
consequence of subunit interaction. Knockdown of NML increased the population of 
cells, emitted a low BiFC signal, and decreased the proportion of cells that emitted a 
high BiFC signal (Fig. II-6C). Consistently, the median of BiFC signals was also 
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decreased by NML KD (Fig. II-6D). 
 
NML contributes to the 60S ribosomal subunit formation without 
changing the protein production rate 
To evaluate the ribosomal subunit formation, I performed sucrose density gradient 
centrifugation under the EDTA existent conditions, which induce the dissociation of the 
80S ribosome complexes into the 40S and 60S subunits (6). In this experiment, the cell 
lysates were centrifuged and fractionated, and the ribosomal subunit ratio was 
quantified by measuring the 18S and 28S rRNA levels in each fraction (Fig. II-7A). The 
ratio of 18S rRNA : 28S rRNA (amount of 18S rRNA was divided by that of 28S rRNA) 
in shNML cells was significantly higher than that of shGFP cells (Fig. II-7B). Notably, 
in these cell lines, 18S and 28S rRNAs were distributed to similar extents in fractions 4-
8 and 9-15, respectively (Fig. II-7A). Considering that this assay separates cellular 
organelles including ribosomal subunits, depending on their individual densities 
(mass/volume), these results indicate that NML reduction results in fewer 60S subunits, 
rather than the formation of abnormal subunits. 
    The primary function of ribosome is protein synthesis. Hence, to investigate 
whether NML depletion alters bulk protein translation, I measured the incorporation of 
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35S-labeled methionine (35S-Met) into polypeptide chains. Pretreatment with protein 
synthesis inhibitor cycloheximide (CHX) substantially blocked amino acid 
incorporation (Fig. II-7C). In NML KD cells, the rates of 35S-Met incorporation were 
not markedly different from those in control cells. Overall, these results suggest that 
NML is involved in the formation of 60S ribosomal subunits without affecting bulk 
protein synthesis. 
 
NML depletion induces the p53 protein accumulation through RPL11 
Abundance of ribosomal proteins outside of the ribosome increases when ribosomal 
biogenesis is perturbed by nucleolar stress (62-64). Several ribosomal proteins, 
including RPL11, bind to MDM2 and inhibit the E3 ubiquitin ligase function of MDM2 
toward p53, leading to p53 accumulation and activation (65-67). To investigate whether 
NML is involved in the regulation of p53 activity through ribosomal proteins, I 
analyzed the levels of RPL11 protein in the ribosome-free fraction by performing 
sucrose density gradient centrifugation under the EDTA absent conditions followed by 
Western blotting. The amount of ribosome-free RPL11 was increased in shNML cells 
(Fig. II-8A), indicating the enhanced RPL11 accumulation outside of the ribosome. 
Furthermore, co-immunoprecipitation experiments showed that the interaction between 
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RPL11 and MDM2 was increased in shNML cells (Fig. II-8B). Considering that p53 
activity in the HeLa cells and immortalized MEFs is inhibited by E6 protein from 
oncogenic HPV type 16 and by SV40 large T-antigen, respectively (68, 69), these cells 
are not suitable for the analysis of p53 functions. Thus, I used human colon carcinoma 
HCT116 p53 wild-type (p53+/+) and null (p53−/−) cells, and investigated the possibility 
that NML depletion induces p53 activation through RPL11. In p53+/+ cells, NML KD 
increased p53 protein levels, and this p53 accumulation was abrogated by the 
concomitant reduction of RPL11 (Fig. II-8C). 
 
NML depletion activates the p53 pathway 
Next, I evaluated the expression of p53 target genes. NML KD upregulated the p53 
target gene expression at both the mRNA and protein levels in p53+/+ cells, but not in 
p53−/− cells (Fig. II-9A, B). Additionally, the increment in the p53 target genes induced 
by NML depletion was also observed in normal MEFs, but not in the immortalized 
MEFs (Fig. II-9C). Taken together, these results indicate that NML deficiency increases 
the RPL11-MDM2 interaction and induces the activation of p53 pathway. 
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NML reduction induces cell cycle arrest and apoptosis, and inhibits 
translation through the p53 pathway. 
p53 contributes to the regulation of cell proliferation by inducing cell cycle arrest and 
apoptosis, or by inhibiting protein synthesis (30-32, 70). Therefore, I investigated the 
effect of NML on these p53-dependent cellular events. Firstly, I performed cell cycle 
analysis, and observed that NML KD decreased the proportion of S-phase cells and 
increased the ratio of G2- and M- (G2/M) phase cells in a p53-dependent manner (Fig. 
II-10A). Moreover, a terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick 
end labeling (TUNEL) assay showed that the percentage of TUNEL-positive cells was 
significantly increased by NML KD in p53+/+ cells, while this was not the case in p53−/− 
cells (Fig. II-10B). Further, the rates of 35S-Met incorporation into synthesized proteins 
were reduced by NML KD in p53+/+ cells (Fig. II-10C). On the other hand, in p53−/− 
cells, the rates of the labeled amino acid incorporation were not significantly changed 
by NML reduction. 
 
NML regulates cell proliferation in a p53-dependent manner 
Finally, I assessed the influence of NML depletion on cell proliferation, and revealed 
that NML KD suppressed cell growth in a p53-dependent manner (Fig. II-11A). 
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Additionally, in both HCT116 p53+/+ and p53−/− cells, NML KD also significantly 
reduced methylation levels around A1309, as well as interactions between ribosomal 
subunits (Fig. II-11B, C). Altogether, these findings suggest that NML modulates the 
large ribosomal subunit formation through m1A modification of 28S rRNA, thereby 
regulating cell proliferation via the p53-dependent mechanisms. 
 
 
 
 
 
34 
 
Discussion 
In this chapter, I showed that the nucleolar protein NML regulates m1A modification of 
28S rRNA through a SAM-binding domain-dependent mechanism (Fig. II-1-4). 
Additionally, NML depletion decreases 60S ribosomal subunit formation (Fig. II-7). 
Intriguingly, I observed that NML depletion induces RPL11-MDM2 interactions and 
increases the levels of p53 protein, thereby activating the p53 pathway (Fig. II-8, 9). 
Consequently, the proliferation of NML-depleted cells is suppressed via p53-dependent 
cell cycle arrest, apoptosis, and protein synthesis inhibition (Fig. II-10, 11). Therefore, 
these results suggest that NML is required for the m1A modification of 28S rRNA, and 
that NML deficiency inhibits cell proliferation in a p53-dependent manner. 
NML was originally identified as an H3K9me2-binding protein that forms a 
complex with SIRT1 and SUV39H1 to suppress rRNA transcription under glucose 
starvation (39). My data raise the question of how the molecular function of NML 
switches from an epigenetic suppressor for rRNA transcription to a base 
methyltransferase of rRNA. Interestingly, some recent reports have shown that NML 
binds to rRNA and also several ribosomal proteins under normal glucose conditions (56, 
71). Conversely, the interaction between NML and rRNA is disturbed after glucose 
deprivation, thereby the recruitment of SIRT1 to NML is enhanced. Indeed, I confirmed 
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that NML interacts with 28S rRNA in HeLa cells (Fig. II-1) and that NML depletion 
does not change the levels of rRNA transcription at a 4.5 g/l glucose concentration (Fig. 
II-5). These results raise the possibility that NML bifunctionally regulates the distinct 
steps of ribosome biogenesis, involving rRNA transcription and methylation, in 
response to environmental changes. 
Of the rRNA modifications, 2’-O-ribose methylation, which affects not only 
ribosome biogenesis but also ribosomal functions, including translational efficiency and 
fidelity (16), is one of the best characterized modifications. Furthermore, Fibrillarin 
(FBL) has been identified as a 2’-O-ribose methyltransferase (42, 72). Recently, it has 
been reported that p53 directly represses FBL gene transcription and decreases the 2’-O-
ribose methylation of rRNAs, and these changes induce the impairment of translational 
function of ribosomes, such as the stop-codon readthrough and amino acid 
misincorporation (37). Furthermore, FBL overexpression facilitates tumorigenesis and 
is correlated to poor survival of cancer-affected individuals (73-75). These observations 
imply that rRNA modification plays a crucial role in cancer development. Intriguingly, 
the levels of m1A-modified nucleosides are elevated in the urine of individuals with 
cancer (76, 77). Hence, my results suggest that the NML-dependent m1A modification 
of rRNA could influence cancer development through the p53 pathway. As a further 
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study, the potential roles of NML-mediated rRNA modifications in cancer development 
should be explored. 
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Fig. II-1   NML binds to 28S rRNA.
(A, B) Interaction between rRNA and NML in whole-cell extracts (A) and nuclear extracts (B) of HeLa cells.
          The binding of NML to 28S or 5S rRNAs was examined with RIP assay using an anti-NML antibody (αNML).
          An conjugated affinity purified immunoglobulin (IgG) from mouse was used as a control. In the left panel in B,
          protein levels of NML in the cytoplasmic or nuclear fractions were determined by Western blotting. α-tubulin
          and histone H3 were used as each fraction marker. Mean values ± S.D. are shown (n = 3). **P < 0.01;
          ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
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(Figures and Figure legends continued on next page)
Fig. II-2   NML is need for methylation of 28S rRNA.
(A) Multiple sequence alignment of the regions neighboring two sites of m¹A (A645 and A2142 in squares) of 25S
      rRNA (633-663 and 2128-2160) in S. cereviaiae, of 28S rRNA (1295-1327 and 3611-3643) in H. sapiens and
      of 28S rRNA (1122-1154 and 3287-3319) in M. musculus are shown. Conserved adenosine ribonucleotides
      focused in this study are marked with asterisks (*).
(B) Schematic representation of the site-specific semi-quantiitative RT-PCR analysis for RNA methylation detection.
      The primers used for reverse transcription and qPCR are indicated as the gray arrows.
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Fig. II-2 (continued)
(C, D) Methylation levels around a region of 28S rRNA, including A1309 or A3625, in HeLa cells expressing shRNAs
           targeting GFP (shGFP) or NML (shNML#1 or #2) were analyzed by qRT-PCR analysis (D). shGFP was used
           as a control shRNA. Protein levels of NML in the indicated cells were determined by Western blotting (C).
          Mean values ± S.D. are shown (n = 3). ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
(E, F) Methylation levels were measured by qRT-PCR analysis around a region of 28S rRNA, including A1136 or
           A3301, in NML WT or KO immortalized MEFs (F). NML protein levels were determined by Western blotting (E).
          Mean values ± S.D. are shown (n = 3). ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
(G) Modification states at A1309 of human 28S rRNA in shGFP- or shNML#2-expressing HeLa cells and at A1136 of
      mouse 28S rRNA in NML WT or KO immortalized MEFs, were analyzed by primer extension method.
(H, I) Expression of FLAG-HA-tagged NML recoverd the methylation levels around A1136 of 28S rRNA in NML KO
         immortalized MEFs, were demonstrated by Western blotting (H) and qRT-PCR analysis (I).
         Mean values ± S.D. are shown (n = 3). ***P < 0.005 (bootstrap and permutation tests).
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Fig. II-3   NML regulates rRNA methylation through its Rossmann-fold methyltransferase-like domain.
(A) Schematic representation of wild-type (wt) and point mutant NML are indicated. The mutations were induced in
      the Rossmann-fold methyltransferase-like domain (mt1 and mt2). Conserved motifs in the SAM dependent-
      methyltransferase are shown as the red bars.
(B) Protein levels of NML in NML WT or KO immortalized MEFs expressing EGFP or FLAG-HA-tagged NML were
      analyzed by Western blotting.
(C) Methylation levels around A1136 of 28S rRNA in the indicated cells were measured by qRT-PCR analysis. Mean
      values ± S.D. are shown (n = 3). ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
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Fig. II-4   NML is related to m¹A modification in 28S rRNA.
(A, B) The amount of m¹A modified ribonucleosides in 28S rRNA of shGFP or shNML#2 transfected HeLa cells (A)
           and of NML WT or KO immortalized MEFs (B) was analyzed by LC-MS/MS.
(C, D) The m¹A levels around A1309 in 28S rRNA of shGFP-or shNML#2-expressing HeLa cells (C) and around
           A1136 in 28S rRNA of NML WT or KO immortalized MEFs were investigated by RIP using an anti-m¹A
           antibody (αm¹A). An unconjugated affinity purified IgG from mouse was used as a control. Mean values ± S.D.
           are shown (n = 3).  **P < 0.01; ***P < 0.005; n.s., not significant (one-way ANOVA followed by Tukey’s test) in
           C. ***P < 0.005; n.s., not significant (Student’s t-test) in D.
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Fig. II-5   NML does not affect the state of rRNA trascription and processing under glucose-rich
                conditions.
(A) The levels of pre (45S)-, 28S and 18S rRNA of HeLa cells transfected shGFP, shNML#1 or #2 were analyzed
      by qRT-PCR. Mean values ± S.D. are shown (n = 3). n.s., not significant (bootstrap and permutation tests).
(B) The states of RNA processing in the indicated cells were investigated by labeling nascent RNA with 32P
      orthophosphate. The representative images of 28S and 18S rRNA analyzed by agarose gel electrophoresis are
      also shown.
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Fig. II-6   NML reduction suppresses the interaction between ribosomal subunits.
(A) Crystal structure of the human ribosome (Protein Databank ID; 4V6X) are shown. RPS18, RPL11 and A1309 of
      28S rRNA are highlighted in different colors. The BiFC model used in this study are also schematically
      represented. In this model, RPS18 and RPL11 are tagged with the N- or C-terminal parts of Venus, respectively
      (S18-VN and L11-VC).
(B-D) The interaction between ribosomal subunits in HeLa cells transfected shRNA targeting Luciferase (shLuc) or
          NML (shNML#1 or #2) was analyzed by BiFC following FACS analysis. The shLuc was used as a control
          shRNA. S18-VN and/or L11-VC were co-transfected into cells with mCherry as a transfection control marker,
          and treated with or without puromycin (Puro). Venus and mCherry emissions (BiFC signals) from shLuc-
          transfected HeLa cells in the indicated conditions detected are indicated in B. The distribution and median of
          the BiFC signals are shown in C and D, respectively. Mean values ± S.D. are shown (n = 3). ***P < 0.005
          (one-way ANOVA followed by Tukey’s test).
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Fig. II-7   NML participates in the 60S ribosomal subunit formation without affecting the protein
                synthesis rate.
(A, B) Ribosomal subunit formation in shGFP-, shNML#1- or shNML#2-transfected HeLa cells were analyzed by
           sucrose density gradient centrifugation following qRT-PCR. 28S and 18S rRNA levels in each fraction were
           normalized against those obtained with non-centrifugated RNA samples (A). The ratios between the total
           amounts of 18S and 28S rRNAs are shown as subunit ratios for the indicated cells (B). Mean values ± S.D.
           are shown (n = 3). *P < 0.05; ***P < 0.005; n.s., not significant (one-way ANOVA followed by Tukey’s test).
(C) The total protein synthesis rates in the indicated cells were measured based on 35S-Methionine incorporation
      into newly synthesized polypeptides. Cycloheximide (CHX) was used as a positive control.
      Mean values ± S.D. are shown (n = 3). ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
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Fig. II-8   NML depletion increases p53 protein levels through RPL11-mediated mechanism.
(A) Protein levels of RPL11 in the ribosome-free (Free) and ribosomal (Ribosome) fraction of shGFP- or shNML#2-
      transfected HeLa cells were analyzed by sucrose gradient density centrifugation followed by Western blotting
      (top three rows). 28S and 18S rRNAs are detected as references for ribosome sedimentation by agarose gel
      electrophoresis (bottom row).
(B) Interaction between RPL11 and MDM2 in shGFP- or shNML#2-transfected HeLa cells was investigated by
      immunoprecipitation (IP) with an anti-MDM2 antibody (αMDM2) followed by Western blotting. An unconjugated
      affinity purified IgG from mouse was used as a control for IP.
(C) Protein levels of p53 in HCT116 p53+/+ cells, which were treated with siRNA targeting Luciferase (siLuc) or NML
      (siNML#1 or #2) and/or RPL11 (siRPL11) for two days, were analyzed by Western blotting. Representative
      Western blotting data are shown. The lower graph indicates the band intensity of p53 normalized that of β-actin.
      Mean values ± S.D. are shown (n = 3). ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
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Fig. II-9 (continued)
Fig. II-9   NML depletion induces the activation of p53 pathway.
(A) The mRNA levels of p53 target genes in HCT116 p53+/+ or p53-/- cells, which were treated with siLuc, siNML#1
      or siNML#2 for three days, were measured by qRT-PCR. Graphs are indicated as the fold change relative to
      corresponding mRNA levels in siLuc-transfected HCT116 p53+/+ or p53-/- cells. Mean values ± S.D. are shown
      (n = 3). *P < 0.05; **P < 0.01; ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
(B) Protein levels of p53 targets in HCT116 p53+/+ or p53-/- cells, which were treated with siLuc or siNML#1 for three
      days, were analyzed by Western blotting. Representative Western blotting data are shown in the left panel.
      The right graphs indicate the band intensity of the indicated proteins normalized that of β-actin. Mean values ± S.D.
      are shown (n = 3). *P < 0.05; **P < 0.01; ***P < 0.005 (bootstrap and permutation tests).
(C) The mRNA levels of p53 target genes in normal and immortalized MEFs (NML WT or KO) were investigated
      by qRT-PCR. In the case of normal MEFs, the cells were treated with siLuc or siNML#1. Three days after
      transfection, the indicated mRNA levels were analyzed. Mean values ± S.D. are shown (n = 3). *P < 0.05;
      ***P < 0.005; n.s., not significant (bootstrap and permutation tests).
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Fig. II-10   NML reduction induces the p53-dependent cellular events.
(A) Cell cycle analysis of HCT116 p53+/+ or p53-/- cells, which were treated with siLuc, siNML#1 or siNML#2 for three
      days, were performed by EdU staining following FACS analysis (left panels). The percentages of cell population
      in the S-phase were compared between the indicated cells, and shown as the graph (right panel). Mean values
      ± S.D. are shown (n = 3). *P < 0.05; ***P < 0.005; n.s., not significant (one-way ANOVA followed byTukey’s test).
(B) Apoptosis assay of HCT116 p53+/+ or p53-/- cells, which were treated with siLuc, siNML#1 or siNML#2 for three
      days, were conducted by TUNEL staining. For each group, cells were counted in three randomly selected fields
      (more than 100 cells/field) per experiment. Mean values ± S.D. are shown (n = 3). *P < 0.05; ***P < 0.005; n.s.,
      not significant (one-way ANOVA followed by Tukey’s test).
(C) The total protein synthesis rates in HCT116 p53+/+ or p53-/- cells, which were treated with siLuc, siNML#1 or
      siNML#2 for three days, were measured based on 35S-Methionine incorporation into newly synthesized
      polypeptides. Mean values ± S.D. are shown (n = 3). **P < 0.01; ***P < 0.005; n.s., not significant (bootstrap and
      permutation tests).
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Fig. II-11   NML regulates cell proliferation in a p53-dependent manner.
(A) Phase-contrast images and growth curves of HCT116 p53+/+ or p53-/- cells, which were treated with siLuc, siNML#1
      or siNML#2, are shown. The phase-contrast images (left panels) were taken three days after siRNA transfection.
      White scale bar: 100 µm. Living cells were automatically counted at the indicated days after transfection by Trypan
      Blue staining (right panels). The statistical significance between siLuc- and siNML#1- or siNML#2-treated cells
      is shown by * and †, respectively. Mean values ± S.D. are shown (n = 3). †P < 0.05; *** or †††P < 0.005; n.s., not
      significant (one-way ANOVA followed by Tukey’s test).
(B) Methylation levels around A1309 of 28S rRNA in HCT116 p53+/+ or p53-/- cells, which were treated with siLuc,
      siNML#1 or siNML#2 for three days, were measured by qRT-PCR analysis. Mean values ± S.D. are shown (n = 3).
          ***P < 0.005 (bootstrap and permutation tests).
(C) The meadian BiFC signals in HCT116 p53+/+ or p53-/- cells, which were treated with siLuc, siNML#1 or siNML#2
      for three days, are shown. The BiFC signals were quantified by FACS analysis. Mean values ± S.D. are shown
      (n = 3). ***P < 0.005 (bootstrap and permutation tests).
Table 1. Primers for qRT-PCR 
 
 
 
 
 
 
  
Species Primer name Sequence (5’ - 3’) 
Human 
45S (pre-) rRNA_Fw CAGGTGTTTCCTCGTACCG 
45S (pre-) rRNA_Rv CACCCGACCCGTCTTGAAAC 
28S rRNA_Fw TCATCAGACCCCAGAAAAGG 
28S rRNA_Rv GATTCGGCAGGTGAGTTGTT 
18S rRNA_Fw AAACGGCTACCACATCCAAG 
18S rRNA_Rv CCTCCAATGGATCCTCGTTA 
5S rRNA_Fw GATCTCGGAAGCTAAGCAGG 
5S rRNA_Rv AAGCCTACAGCACCCGGTAT 
NML_Fw CCTAGAGGAGGCAAATAGAG 
NML_Rv CAGGTCCTTGGAGACAATC 
MDM2_Fw CATGCCTGCCCACTTTAGA 
MDM2_Rv GGAGGCTCCCAACTGCTT 
14-3-3V_Fw TTGTGGCTGAGAACTGGACA 
14-3-3V_Rv ACACCCAGCAGACATGCTTT 
BAX_Fw ATGTTTTCTGACGGCAACTTC 
BAX_Rv ATCAGTTCCGGCACCTTG 
PUMA_Fw TTGTGCTGGTGCCCGTTCCA 
PUMA_Rv AGGCTAGTGGTCACGTTTGGCT 
NOXA_Fw GTGCCCTTGGAAACGGAAGA 
NOXA_Rv CCAGCCGCCCAGTCTAATCA 
E-actin_Fw CCAACCGCGAGAAGAT 
E-actin_Rv CCAGAGGCGTACAGGG 
   
Species Primer name Sequence (5’ - 3’) 
Mouse 
NML_Fw AGTGGACCGTATTGCCAAAGATC 
NML_Rv ATCAAAACAGTGCACAGGGTTCC 
Mdm-2_Fw CTCTGGACTCGGAAGATTACAGCC 
Mdm-2_Rv CCTGTCTGATAGACTGTCACCCG 
PUMA_Fw GTACGAGCGGCGGAGACAAG 
PUMA_Rv GCACCTAGTTGGGCTCCATTTCTG 
Noxa_Fw GAAGTCGCAAAAGAGCAGGATGAG 
Noxa_Rv TGCCGTAAATTCACTTTGTCTCCA 
Cyclophilin_Fw TGCCAGGGTGGTGACTTTACA 
Cyclophilin_Rv GCCATCCAGCCATTCAGTCTTG 
Table 2. Primers for the site-specific semi-quantitative RT-PCR 
 
 
 
 
Species Primer name Sequence (5’ - 3’) 
Human 
A1309_RT CGGCCTTCACCTTCATTG 
A1309_Fw CACCCGACCCGTCTTGAAAC 
A1309_Rv ACTCGCGCACGTGTTAGAC 
A3625_RT CGCGCTTCATTGAATTTCTT 
A3625_Fw CAGGGGAATCCGACTGTTTA 
A3625_Rv CGCGCTTCATTGAATTTCTT 
Mouse 
A1136_RT GGCCCTTCACCTTCATTG 
A1136_Fw CACCCGACCCGTCTTGAAAC 
A1136_Rv CCTGACTCGCGCACGCGTTA 
A3301_RT CGCGCTTCATTGAATTTCTT 
A3301_Fw CAGGGGAATCCGACTGTTTA 
A3301_Rv CGCGCTTCATTGAATTTCTT 
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Chapter III. 
Identification of rRNA adenine methyltransferase-1 (RRAM-1) as 
m1A modification factor in Caenorhabditis elegans 
Abstract 
RNAs are post-transcriptionally modified in all kingdoms of life. The RNA 
modifications play important roles in the regulation of RNA stability and function. Of 
these modifications, base methylations are highly conserved in eukaryote ribosomal 
RNA (rRNA). Recently, yeast rRNA processing protein 8 (Rrp8) and mammalian 
nucleomethylin (NML) were identified as factors of N1-methyladenosine (m1A) 
modification in yeast 25S and mammalian 28S rRNA, respectively. However, the 
physiological role of m1A modification in rRNA is still poorly understood. 
Here, using the liquid chromatography/tandem mass spectrometry (LC-MS/MS) 
analysis and RNA immunoprecipitation (RIP) assay, I identified that an m1A 
modification is located around position 674 (A674) of Caenorhabditis elegans (C. 
elegans) 26S rRNA. Furthermore, quantitative PCR-based analysis revealed that 
T07A9.8, a C. elegans homolog of yeast Rrp8 and mammalian NML, is responsible for 
the m1A modification at A674 of 26S rRNA. This m1A modification site in C. elegans 
corresponds with those in yeast 25S rRNA and mammal 28S rRNA. Intriguingly, 
T07A9.8 is not associated with transcription and processing of rRNA under normal 
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nutrient conditions. Because of the functional diversities among T07A9.8, Rrp8, and 
NML, I renamed the T07A9.8 gene as rRNA adenine methyltransferase-1 (rram-1). 
The further in vivo analysis demonstrated that RRAM-1 reduction induces 
autophagy and significantly extends the lifespan under normal feeding environments. 
Thus, my findings suggest that the m1A modification of 26S rRNA contributes to 
the regulation of autophagy and lifespan in C. elegans. 
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Introduction 
RNA functions as a fundamental molecule that conveys the genetic information from 
DNA into protein. In each steps, messenger RNA (mRNA) is transcribed from DNA and 
translated by ribosome that is composed of ribosomal RNAs (rRNAs) and ribosomal 
proteins. During translation, transfer RNAs (tRNAs) bring specific amino acids to 
elongating polypeptides through codon-specific pairing with mRNA on the ribosomes. 
Therefore, RNAs represent central factors throughout the gene expression processes. 
RNAs are modified post-transcriptionally in all kingdoms of life. To date, more 
than 100 different types of modifications have been identified (1, 18, 78). These 
modifications play roles in structural and functional control of RNA, cellular 
homeostasis maintenance, stress response, development, and so on (16, 58, 59, 79-81). 
Furthermore, the fields of RNA modification have been noted owing to the discoveries 
that some RNA modifications are dynamically and reversibly regulated (82-85). 
Although a wide variety of RNA modifications exist, ‘RNA methylation’ accounts for 
approximately two third of the known chemical modifications occurring with RNAs. 
The methylations of RNA are induced at almost all nitrogen of the nucleobases (base 
methylation) and also at the oxygen of the ribose 2’-OH (2’-O-ribose methylation) (86). 
Since the methods for detection and quantification of RNA methylation is highly 
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developed, new enzymes and modification sites are rapidly identified (87). 
Among these modifications, N1-methyladenosine (m1A) modification was first 
discovered in yeast total RNA (88) and later found in tRNAs and rRNAs from several 
species (4, 89). These modifications have been shown to modulate the structural 
stability and function of these RNAs (3, 90). Within a few years, it has been reported 
that m1A modifications present in mRNAs and also they are reversibly regulated by the 
methyltransferases and demethylases (91-94). Thus, these findings further emphasize 
the biological significance of this modification. However, the physiological functions of 
m1A modification are poorly understood. 
Nucleomethylin (NML) is a nucleolar protein that modulates rRNA transcription 
through the epigenetic regulation and protects cells from energy deprivation-induced 
apoptosis (39). In addition to this function, as described in chapter II, I have revealed 
that NML regulates the m1A modification of 28S rRNA, thereby modulating the 
ribosomal subunit formation and cell proliferation in mammalian cells (95). Although 
the cellular functions of NML were investigated, its contribution to in vivo events as an 
m1A modification factor is largely unknown. 
Caenorhabditis elegans (C. elegans) is a small nematode. Because of its short life 
cycle (about 2-3 weeks), C. elegans is a suitable model organism for fundamental 
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biological studies, such as development, behavior and aging (7, 8). Furthermore, the 
genetic and metabolic pathways between C. elegans and mammals are highly conserved 
(96, 97). Indeed, database searching for C. elegans proteins has revealed that T07A9.8 
is a putative homolog of yeast Rrp8 and mammalian NML, which are responsible for 
the m1A modification of yeast 25S and mammalian 28S rRNA, respectively (57). 
However, the presence of m1A modification in C. elegans 26S rRNA and the 
contribution of T07A9.8 to this modification remain to be elucidated. 
Here, using a RIP assay and a site-specific semi-quantitative RT-PCR analysis, I 
showed that T07A9.8 is required for the m1A modification of 26S rRNA without 
changing the rRNA transcription. On the basis of its function, I renamed the T07A9.8 
gene as rRNA adenine methyltransferase-1 (rram-1). As a physiological function of 
rram-1, I observed that RRAM-1 is involved in lifespan regulation. Moreover, RRAM-1 
reduction induced the autophagosome formation, which might link rRNA m1A 
modification to the regulation of lifespan. 
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Materials and Methods 
Worms 
Worm strains were maintained as described previously (98, 99). The Bristol N2 strain 
was obtained from the Caenorhabditis Genetics Center and used as a wild-type strain in 
this study. The bacterial strain E. coli OP50 was used as a food source for C. elegans. 
 
RNA interference experiment 
T07A9.8 #1 RNAi clone was isolated from Ahringer’s RNAi library and verified by 
sequencing the insert. For T07A9.8 #2 clone, a 500-bp nucleotide fragment, nucleotides 
21-520 of the T07A9.8 gene, was amplified. The T07A9.8 DNA fragment was cloned 
into the RNAi feeding vector L4440. The primer sequences for amplification of the 
fragment were as follows: 
Forward primer, 5’- TACGGATGAAAAGGATGCTC -3’ 
Reverse primer, 5’- CAGCAAATCCCTTGTGATAT -3’. 
HT115 (DE3) bacteria were transformed with the RNAi vector expressing dsRNA 
of the genes of interest and cultured on LB plates with 50 Pg/ml ampicillin and 
10 Pg/ml tetracycline. Each single colony was inoculated in 3 ml of LB containing 
ampicillin and grown for 6-12 h. These cultures were seeded on NGM plates containing 
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25 Pg/ml carbenicillin and 1 mM isopropylthiogalactoside. To induce dsRNA 
expression, these plates were incubated at room temperature overnight. Worms grown 
on these RNAi plates were harvested and used for experiments. 
 
Antibodies 
The following antibodies were used in my study: anti-E-actin (M177-3; MBL, Japan); 
anti-1-methyladenosine (D345-3; MBL); anti-LC3 (PM036; MBL); anti-GFP (D5.1) XP 
(#2956; Cell Signaling Technology, USA); and normal mouse IgG (sc-2025; Santa Cruz 
Biotechnology, USA). The rabbit anti-C. elegans T07A9.8 antibody was raised against a 
synthetic peptide corresponding to 30-45 amino acids of the T07A9.8 protein. A rabbit 
anti-mouse NML antibody was previously prepared (40). Horseradish peroxidase-linked 
(HPL) sheep anti-mouse IgG (NA931; GE Healthcare, UK) and HPL donkey anti-rabbit 
IgG (NA934; GE Healthcare) were used as secondary antibodies for Western blotting. 
 
Quantification of methylated ribonucleosides with liquid 
chromatography/tandem mass spectrometry (LC-MS/MS) 
Large RNAs were extracted with ISOGEN II (Nippon Gene, Japan) according to the 
manufacturer’s protocols. To quantify the methylated ribonucleotides in rRNA, 26S 
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rRNA and 18S rRNA were isolated from large RNAs by performing agarose gel 
electrophoresis and gel extraction with the NucleoSpin® Gel and PCR Clean-up system 
(MACHEREY-NAGEL, Germany) according to the instruction manual. One unit of 
nuclease P1 (Wako Pure Chemicals, Japan) was added to the heat-denatured RNA 
sample (1 to 2 Pg) in 10 mM ammonium acetate buffer (pH 5.3) and then incubated for 
2 h at 45 °C. Subsequently, the sample was dephosphorylated by additions of venom 
phosphodiesterase I (0.0002 unit, Sigma, USA) and bacterial alkaline phosphatase (0.3 
unit, Toyobo, Japan) in 0.1 M ammonium bicarbonate buffer (pH 7.9) for 2 h at 37 °C, 
as previously described (45). As an internal standard, 10 pmol of 5-bromouridine (br5U, 
Tokyo Chemical Industry Co., Ltd., Japan) were added into the digestion mixture and 
enzyme proteins were subsequently removed by acetone precipitation. The supernatant 
was evaporated to dry up and the resulting nucleoside residues were dissolved with 15 
Pl of HPLC-grade water (Wako Pure Chemicals). 
LC-MS/MS analyses were performed on a Shimadzu NexeraTM UHPLC system 
coupled to LCMS-8050TM triple quadrupole mass spectrometer (Shimadzu, Japan). LC 
separations were carried out on a Inertsil ODS-HLTM column (3 Pm, 2.1 × 150 mm, 
GL Science, Japan) with a Inertsil ODS-HLTM Cartridge Guard Column (3 Pm, 3.0 × 
10 mm, GL Science) at 30 °C, with a flow rate of 0.2 ml/min. The mobile phase 
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consisted of solvent A (0.1% formic acid) and solvent B (0.1% formic acid in 80% 
acetonitrile). The water-dissolved samples (5 Pl) were injected and eluted starting with 
100% solvent A / 0% solvent B for 6 min, followed by a 20 min linear gradient of 0 to 
10% solvent B, an one min linear gradient of 10% to 100% solvent B, 5.5 min with 
100% solvent B, and 6 min re-equilibration with the initial mobile phase conditions. For 
determining of elution positions of ribonucleosides on the chromatogram, standard 
chemicals of adenosine (A, Sigma), m1A (Santa Cruz Biotechnology), cytidine (C, 
Sigma), 5-methylcytidine (m5C, Sigma), and br5U were used, and their retention times 
were revealed as 19.45 min, 9.47 min, 3.9 min, 9.12 min, and 24.0 min, respectively. 
The mass spectrometer was operated using an ion-spray source at 300 °C in the 
positive mode with unit resolution for Q1 and Q3, and other optimized parameters as 
follows: interface voltage, 4.0 kV; interface current, 0.1 PA; flow rate of nebulizer gas, 
3 l/min; flow rate of heating gas, 10 l/min; flow rate of drying gas, 10 l/min; collision 
gas (Ar), 270 KPa; DL temperature, 250 °C; heat block temperature, 400 °C; conversion 
dynode potential, 10 kV; detector potential, 2.44 kV. The multiple reaction monitoring 
(MRM) transitions and parameters (cone voltage and collision energy of precursor and 
product ions, respectively) for each nucleoside is listed in Methylated nucleosides 
database (MNSDB, http://www.agbi.tsukuba.ac.jp/~akiftara/MNSDB/). 
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qRT-PCR 
Total RNA was extracted using ISOGEN II (Nippon Gene) and treated with DNase I 
(Nippon Gene) according to the manufacturer’s instructions. Extracted total RNA (1 Pg) 
was reverse transcribed with random primers (TaKaRa, Japan) and ReverTra Ace 
(Toyobo) according to manufacturer’s protocols. The qRT-PCR was performed with 
SYBR Premix Ex Taq II (TaKaRa) and the Thermal Cycler Dice Real Time System 
(TaKaRa). Each gene-expression level was normalized to the act-1 expression level. 
 
Western blotting 
Worms were lysed in RIPA buffer [20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM 
EDTA, 0.8% NP-40, 0.1% SDS, 0.5% sodium deoxycholate] containing protease 
inhibitor cocktail (Nacalai Tesque, Japan). The extracts were subsequently separated by 
10% or 15% SDS-PAGE. The proteins were transferred to Immobilon-P polyvinylidene 
difluoride transfer membranes (Millipore, USA). After blocking with 0.3% skim milk 
containing TBS-T buffer [20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Tween-20] 
for 1 h at room temperature, the membranes were incubated overnight at 4 °C with the 
indicated primary antibodies. After washing with TBS-T buffer, the membranes were 
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incubated with HRP secondary antibodies for 1 h at room temperature and then washed 
again with TBS-T buffer. Protein signals were detected with Luminata Forte Western 
HRP substrate (Millipore). 
 
RIP experiment 
Total RNA extracted from worms were fragmented using the NEBNext Magnesium 
RNA Fragmentation Module (New England BioLabs, USA). After ethanol precipitation 
with 20 Pg of glycogen, fragmented RNAs were resuspended in IPP buffer [10 mM 
Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP-40]. Solutions containing 1 Pg anti-m1A 
antibody, 50 Pl of 50% slurry protein G Sepharose 4 Fast Flow (GE Healthcare), and 
950 Pl IPP buffer were added to the pre-cleaned RNA solutions. The mixture was 
rotated overnight at 4 °C. The beads were washed 3 times with IPP buffer and 
immunoprecipitated RNAs were purified by phenol/chloroform extraction. After ethanol 
precipitation, RNAs were analyzed by qRT-PCR. Total RNAs were used as input for 
normalization of qRT-PCR data. 
 
Site-specific semi-quantitative RT-PCR 
Methylation of 26S rRNA was analyzed by the similar method described in chapter II. 
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Five hundred nanograms of extracted total RNA were reverse transcribed with 50 units 
of ReverTra Ace (Toyobo), 1.25 µM of the methylated site unanchored or anchored 
primer, and either low (0.25 µM) or high (250 µM) concentrations of deoxynucleotide 
triphosphates (dNTPs). The reactions were performed at 42 °C for 60 min, and then 
stopped by incubation at 99 °C for 5 min. The following qRT-PCR was performed with 
SYBR Premix Ex Taq II and the Thermal Cycler Dice Real Time System. The 
methylation levels were calculated as 2(CTlow - CThigh), where the CT (threshold cycle) 
value obtained with the qRT-PCR reaction at the low dNTP concentration was 
normalized to that obtained at the high dNTP concentration. 
 
Lifespan analysis 
I performed lifespan analysis using the wild-type N2 strain as described previously (98, 
99). Briefly, I transferred 30-35 synchronized L1 larvae to each RNAi plate, allowed the 
worms to develop into adults, and then added 300 Pl of 0.5 mg/ml fluorodeoxyuridine 
solution. Worms were kept at 20 °C and transferred to fresh plates every 4-6 days. 
Worms feeding on bacteria carrying the empty vector (L4440) were used as control. I 
monitored the worm populations regularly. 
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Statistical analysis 
Data are presented as the mean ± standard deviation. The statistical significances were 
determined by one-way analysis of variance (ANOVA), followed by Dunnett’s test. A P 
value < 0.05 was considered statistically significant. For lifespan analysis data, Kaplan-
Meier survival curves were plotted, and log-rank statistics were calculated. 
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Results 
m1A modification is present in C. elegans 26S rRNA 
To evaluate the presence of m1A modification and quantify its levels in 26S rRNA, I 
firstly isolated the 26S- and 18S-rRNA, and performed liquid chromatography/tandem 
mass spectrometry (LC-MS/MS) analysis to measure the RNA modifications. In 26S 
rRNA, the chromatogram peak corresponding to that from an m1A chemical standard 
was clearly detected. Therefore, I next tried to quantify the m1A modification levels. 
Additionally, to ensure the m1A existence, I also assessed the amount of 2’-O-
methyladenosine (Am) and 5-methylcytidine (m5C), which are modifications identified 
in C. elegans 26S rRNA (23, 100). The ratios of m1A/A, Am/A, and m5C/C were 
0.588% ± 0.164, 1.379% ± 0.084, and 0.954% ± 0.217, respectively. Accordingly, from 
LC-MS/MS analyzes, I demonstrated that the N1 position methylated adenosine exists in 
C. elegans 26S rRNA. 
 
Methyltransferase-like domain is highly conserved in C. elegans 
T07A9.8 
Recently, NML and Rrp8 were identified as enzymes responsible for the m1A 
modification of rRNA in humans (reported in chapter II) and yeast, respectively (6, 95). 
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However, an enzyme that catalyzes this type of modification in nematodes has not been 
identified. Hence, I conducted a database search of C. elegans proteins, based on amino-
acid sequence similarity to the mammalian NML protein, and identified a single 
putative homolog, T07A9.8, consistent with a previous report (57). The T07A9.8 gene 
encodes a 343-amino acid protein. Alignment of the T07A9.8 amino acid sequence with 
homologs revealed that T07A9.8 shares 34% and 29% amino acid identity with the 
human NML and yeast Rrp8 proteins, respectively. Furthermore, I confirmed that the 
putative RNA methyltransferase domain, composed of four consensus motifs (motif I, 
post-I, motif II and III), is highly conserved among these proteins. 
 
T07A9.8 is not involved in the regulation of rRNA transcription 
Human NML functions as not only a rRNA methyltransferase, but also an epigenetic 
suppressor of rRNA gene transcription (39, 95). Therefore, I examined whether this 
function as a rRNA transcription repressor is conserved in the T07A9.8 protein. At first, 
I performed the knockdown of T07A9.8 with two different RNAi clones and revealed 
that both clones effectively reduced its expression at the mRNA and protein levels. 
Next, I evaluated pre-rRNA levels in nematodes by RT-PCR. T07A9.8 RNAi did not 
induce obvious changes in the pre-rRNA levels. In addition, the qRT-PCR and agarose 
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gel electrophoresis experiments showed that the levels of three major rRNA species 
(26S, 18S and 5.8S rRNA) did not significantly altered in T07A9.8 RNAi worms. 
Therefore, these observations suggest that T07A9.8 does not contribute to the regulation 
of rRNA transcription processes under the normal feeding conditions examined in my 
study. 
 
m1A modification exists within the sequences around A674 of 26S 
rRNA 
The two and one m1A modification sites in 25S rRNA of S. cerevisiae (A645 and 
A2142) and 28S rRNA of H. sapiens (A1309) are well conserved in C. elegans 26S 
rRNA. To investigate the participation of T07A9.8 in the m1A modification of 26S 
rRNA, I performed RIP assays with an antibody against m1A to pull down m1A-
modified rRNA. And I found that the region adjacent to adenosine at 674 of 26S rRNA 
was enriched in m1A-precipitated RNA more than that in control IgG. Furthermore, 
compared to control RNAi, both T07A9.8 RNAi clones significantly diminished anti-
m1A antibody (Dm1A) precipitated-RNA levels. In chapter II, I confirmed that the 
A3625 of human 28S rRNA correspond to A2142 of yeast 25S rRNA is not modified 
(95). The RIP assays using primers flanking A2246 of 26S rRNA revealed that the 
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region around A2246 does not contain the m1A residues. Considering that yeast Bmt2, a 
responsible factor for m1A2142 modification of yeast 25S rRNA, is not conserved in C. 
elegans, this result is reasonable. Taken together, these data indicated that the m1A 
modification occurs around A674 of 26S rRNA and that T07A9.8 is involved in the 
methylation. 
 
T07A9.8 is required for m1A modification at position 674 of 26S rRNA 
To further investigate the m1A modification of 26S rRNA in detail, I performed a site-
specific semi-quantitative reverse transcriptase-PCR (qRT-PCR) analysis. This method 
is based on the principle that modified residues (including m1A or 2c-O-methylation) 
induce a pause in the reverse transcriptase reaction at low dNTP concentrations, but not 
at high dNTP concentrations (Chapter II; Fig. II-2B). Consistent with RIP assays, the 
methylation levels around A674 were clearly detected (15.16 ± 0.47), and RNAi against 
T07A9.8 markedly reduced the methylation levels (8.07 ± 0.79 and 6.68 ±1.53 for RNAi 
constructs #1 and #2, respectively). Therefore, I concluded that adenosine around 
position 674 of 26S rRNA is methylated at the N1 position via a T07A9.8-dependent 
mechanism. 
Next, to determine the precise position of the modified residue around A674, I 
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designed some types of specific reverse primers for the RT reaction and qPCR that were 
shifted several nucleotides neighboring a target site in 26S rRNA. From these analysis, I 
confirmed that A674 of 26S rRNA is methylated at N1 position through the T07A9.8-
mediated regulation. Based on the function of T07A9.8, I renamed this gene as rRNA 
adenine methyltransferase-1 (rram-1). 
 
RRAM-1 reduction leads to lifespan extension and autophagosome 
formation 
Finally, I explored the physiological function of RRAM-1. Recently, it has been 
reported that the depletion of nsun-5, which is responsible for the m5C modification of 
26S rRNA, induces longevity under a nutrient-restricted condition (23). Furthermore, 
the genome-wide RNAi screening experiments suggested that inactivation of T07A9.8 
(rram-1) gene extends C. elegans lifespan (101, 102). Therefore, I evaluated the relation 
between rram-1 and the lifespan regulation, and revealed that rram-1 RNAi 
significantly increased the mean lifespan by about 12% compared to control RNAi. 
The various cellular processes modulating lifespan have been reported (103, 104). 
Autophagy is a well-conserved cellular recycling system that also plays a key role in 
anti-aging (9-12). Intriguingly, I noticed that NML-knockout immortalized mouse 
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embryonic fibroblasts (MEFs) exhibited a higher amount of LC3-II expression, which is 
a well-used indicator for autophagy, compared with NML wild-type MEFs. To examine 
the roles of RRAM-1 in autophagy, I used the transgenic worms carrying GFP::LGG-1, 
which is a reliable tool for evaluating autophagy (105, 106). Western blotting analysis 
demonstrated that the amount of phosphatidylethanolamine (PE)-conjugated LGG-1 
(PE-GFP::LGG-1), an indicator of autophagosome formation, increased in rram-1 
RNAi worms. These results imply a possible mechanism that rram-1 knockdown 
extends the lifespan through modulating autophagy. 
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Discussion 
In the present study, I showed that m1A modification is existing at position 674 of 26S 
rRNA in C. elegans. Additionally, my findings indicate that T07A9.8, a C. elegans 
homolog of yeast Rrp8 and human NML, is responsible for this modification without 
changing rRNA transcription under the normal feeding conditions. Taking the functional 
diversity into consideration, I designated the T07A9.8 gene as rRNA adenine 
methyltransferase-1 (rram-1). Intriguingly, from the lifespan analysis, I confirmed that 
RNAi-mediated reduction of RRAM-1 induces longevity. From these findings, I suggest 
the possibility that RRAM-1 links the m1A modification of rRNA to lifespan regulation. 
However, to clearly prove this point, further work is needed using methyltransferase 
activity-deficient RRAM-1 mutant. 
Several studies have used a qRT-PCR-based method to examine the presence of 
methylated residues within RNA using the flanked PCR primers (34, 35, 95). This 
method is based on the principle that some kinds of modified residues prevent 
polymerase chain reaction at low dNTP concentrations. However, these studies did not 
identify the precise position of the modified residue due to the use of a single primer for 
the RT step. To resolve this issue, I made use of “Reverse Transcription at Low dNTP 
concentrations followed by PCR (RTL-P) assay” established by Dong et al. (107). 
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Although they detected the PCR products by agarose gel electrophoresis, I successfully 
detected them by qRT-PCR. In addition, at the RT reaction, I used primers that were 
shifted one base at a time around a putative modification residue. Intriguingly, when the 
3c-end of the primer covers just on the modified residue, the methylation levels detected 
were markedly reduced. These data suggest that my improved method can be used to 
identify the position of methylated residues at single-nucleotide resolution. Therefore, 
this tool will help map RNA modifications, including m1A and 2c-O-methylation. 
Yeast Rrp8 and mammalian NML have been identified as a methyltransferase 
responsible for the m1A modification of 25S rRNA (6) and 28S rRNA (95), respectively. 
In this study, I provide evidence that RRAM-1 is required for the m1A modification at 
position 674 of 26S rRNA in C. elegans. Indeed, the amino acid sequence alignment of 
RRAM-1 with Rrp8 and NML shows a high degree of conservation in their C-terminal 
region, which includes the methyltransferase-like domain. Meanwhile, RRAM-1 hardly 
contributed to the regulation of rRNA transcription under normal nutrient conditions. 
Mammalian NML binds to histone H3 dimethylated Lsy9 through its N-terminal region 
and acts as an epigenetic inhibitor of rRNA transcription under low glucose conditions 
(39). Although I have not yet examined whether RRAM-1 controls rRNA transcription 
under the nutrient-depleted conditions, a low sequence similarity of the N-terminal 
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region between RRAM-1 and NML might lead to the functional difference in regard to 
the regulation of rRNA transcription. 
Intriguingly, RNAi-mediated rram-1 reduction significantly extends the lifespan. 
Although this finding agrees with the preceding data observed by genome-wide RNAi 
screening (101, 102), the mechanisms how RRAM-1 regulates the lifespan are largely 
unknown. Recently, Schosserer et al. showed that the reduction of nsun-5, which is a 
responsible factor of m5C modification of 26S rRNA, increases the lifespan in C. 
elegans under the nutrient-restricted environments. They mentioned that the absence of 
m5C modification alters the translation quality, thereby induces the lifespan extension. 
Considering that the m1A modification of rRNA in yeast and mammal is involved in the 
ribosome formation (6, 95), I propose a possible mechanism that the RRAM-1-mediated 
change of translation contributes to the lifespan regulation. 
    Importantly, I found that RRAM-1 and NML could be related to the regulation of 
autophagy in my study. Western blotting experiments revealed that the reduction of 
RRAM-1 and NML increased the lipidated forms of LGG-1 and LC3-II, respectively. 
Until now, there have been many evidences that autophagy plays a key role in lifespan 
regulation (9-12). Therefore, my observations about the autophagic phenotype induced 
by RRAM-1 down-regulation suggest that autophagy links the rRNA m1A modification 
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to the regulation of lifespan. 
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Chapter IV. 
Concluding Remarks 
RNAs, including mRNA, tRNA and rRNA, play fundamental roles in gene transduction 
processes. These RNAs are modified post-transcriptionally in all three domains of life 
(Archaea, Bacteria, and Eukaryota). There are over 100 different chemical types of 
RNA modifications (1). Although roles for DNA and protein modifications in the 
regulation of gene expression are well-established, much less is understood about how 
RNA modifications modulate RNA functions and affect diverse biological phenomena. 
Among the known RNA modifications, the m1A modification, one of the base 
methylations, has been identified in all three major RNA species (mRNA, tRNA, and 
rRNA). Extensive enzymological and functional analyses have been conducted in 
tRNAs (3-5, 108). In contrast, the responsible methyltransferases and the physiological 
functions of the rRNA m1A modification, especially in multicellular organisms, are 
largely unknown. 
Remarkably, in a recent report, yeast Rrp8 has been identified as the first 
methyltransferase responsible for the m1A modification of yeast 25S rRNA (6). Thus, in 
chapter II, I focused on mammalian NML, which is a homolog of yeast Rrp8, and 
demonstrated that NML is required for the m1A modification of human and mouse 28S 
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rRNA, which corresponds with yeast 25S rRNA. Furthermore, I revealed that NML 
contributes to formation of the 60S ribosomal subunit. Considering that 28S rRNA is a 
major component of the 60S ribosomal subunit, the NML-mediated m1A modification 
may be important for maintaining its conformation. Importantly, depleting NML 
suppresses cell proliferation in a p53-dependent manner. These results suggest a novel 
role of rRNA m1A modification in mammal, which links ribosome biogenesis to the 
p53-mediated regulation of cell proliferation. 
RNA methylations are regulated not only by methyltransferases but also by 
demethylases (82-85). In the case of the m1A modification, m1A demethylases were 
identified in mammalian mRNA and tRNA within the past decade (91-94). On the other 
hand, it is totally unknown whether the rRNA m1A modification is reversible. Further 
studies are needed, and the unraveling of this point would promote our grasp of RNA 
modification dynamics. 
Previously, the in vivo function of the rRNA m1A modification was largely 
unknown. In chapter III, to address this issue, I examined the function of T07A9.8 
(RRAM-1), which is the C. elegans homolog of human NML. From these 
investigations, I identified the existence of an m1A modification in C. elegans 26S 
rRNA for the first time and demonstrated that RRAM-1 is responsible for this 
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modification. Moreover, I found that RRAM-1 is involved in regulating autophagy and 
lifespan. Intriguingly, it has been considered that autophagy plays a key role in 
longevity (9-12). In conclusion, these novel discoveries suggest that the rRNA m1A 
modification links autophagy to the regulation of lifespan in multicellular organisms. 
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